Markus Hörer - Info zur Person mit Bilder, News & Links



	AAV Chief Technology Officer Kerstin Pharma Emmerling Karlheinz Holzmann Verena Michaelis Ascend Erika Nathwani

News

Cathay Health Backed Ascend Gene & Cell Therapies ...private-equitynews.com

www.private-equitynews.com

— ... Chief Scientific Officer Markus Hörer who began his career in AAV over 30 years ago and brings significant expertise in developing AAV ...

Ascend Gene & Cell Therapies launches with $130MLabiotech.eu

www.labiotech.eu

— ... also includes chief financial officer Wes McConnell, chief scientific officer Markus Hörer, and chief operating officer Arjan Roozen.

Vetmeduni Vienna: Virale Partikel unterstützen vorbeugende ...

www.lisavienna.at

— ... Mirko Ritter, Kerstin Pino Tossi, Markus Hörer, Uwe Michaelis und Erika Jensen-Jarolim wurde im Journal OncoImmunology veröffentlicht. › news › vetmeduni-vienna-viral...

Netzwerk-Profile

(1 - 4 von 8

–alle anzeigen

)

: Markus Hörer aus Studiengänge

StayFriends - Schulfreunde wiederfinden

Facebook: Markus Hörer voll im Einsatz | By Camp Kaub | Facebook

Facebook: Markus Hörer - Hallo grüsse aus Flacht, ihr seit eine...

LinkedIn: Markus Hörer | LinkedIn

Sehen Sie sich das berufliche Profil von Markus Hörer (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und ...

Private Homepages

About - 2A Pharma2A Pharma

2apharma.com

2A Pharma's history starts in when John Nieland, then Head of Immunology at Medigene AG together with colleagues Markus Hörer and Hildegard Büning, ...

Bücher

Proof of concept study with an HER-2 mimotope anticancer ...Taylor & Francis Online

www.tandfonline.com

von J Singer · · Zitiert von: 24 — Markus Hörer, Mirko Ritter and Kerstin Pino Tossi are inventors of the AAV related patent application WO “Mutated structural protein of a ...

Dokumente zum Namen

(1 - 3 von 6

–alle anzeigen

)

Temperature‐sensitive miR‐483 is a conserved regulator ...John Wiley

onlinelibrary.wiley.com

von VV Emmerling · · Zitiert von: 35 — Markus Hörer,. Markus Hörer. Rentschler Biotechnologie GmbHLaupheim, Germany. VBBio Consultant, Auf dem Berg 17, ...

BIOTECH IN BAVARIA - Bio M

www.bio-m.org

Dr. Markus Hörer. . D Planegg. . Internet: www.freelinetx.com. FRIZ Biochem Gesellschaft für. › Uploads › Downloads ›

Investing to extend and enhance human lifePublic Technologies

docs.publicnow.com

— Markus Hörer, Founder and Chief Technology Officer (over 30 years' experience working in AAV biology, as well as over 23 years'.

Veröffentlichungen allgemein

Volume 7, supplement issue 6, December SpringerLink

link.springer.com

Verena V Emmerling; Karlheinz Holzmann; Markus Hörer. Content type: Poster presentation; Open Access; Published: 04 December 2013; Article: P › journal

Artikel & Meinungen

Laupheim to become an international forum for ...

www.gesundheitsindustrie-bw.de

— Rentschler Biotechnologie GmbH's Markus Hörer spoke about virus-based biologics and the potential of cell culturing for the new class of ... › ...

Sonstiges

(1 - 20 von 37

–alle anzeigen

)

EP A1 - Système plasmidiqueGoogle

patents.google.com

Application number: EP A; Other languages: German (de) · English (en); Inventor: Markus HÖRER: Florian Sonntag: Renée KOBER; Current Assignee (The ...

Markus Hörer Email, Phone Number, Company, Colleagues ...

aeroleads.com

› markushoerer

424B410jqka.com.cn

basic.10jqka.com.cn

Our co-founder and Chief Technology Officer, Markus Hörer, is a leading expert on AAV analytics and manufacturing. Dr. Hörer leads our AAV platform ...

78F0 Stock Price and Chart — FWB:78F0 - TradingViewtradingview.com

www.tradingview.com

The company was founded by Markus Hörer and Amit Chunilal Nathwani in and is headquartered in Stevenage, the United Kingdom. Show more ...

xls

freeline.gcs-web.com

9, Markus Hörer, Ph.D. 81,000, $ 8.6540,000, $ 3.01Mark Baldry, 32,800, $ 8.65, › static-files

2a Pharma Careers and Jobs - Drjobs - Drjobcareer.com

www.drjobcareer.com

The story of the technology behind our company started in when John Nieland, then Head of Immunology at Medigene AG, and colleagues Markus Hörer and ... › co...

Development of AAVLP(HPV16/31L2) particles as broadly ...Johns Hopkins University

pure.johnshopkins.edu

von K Nieto · · Zitiert von: 80 — ... Hanna Seitz, Martin Müller, Markus Kellner, Markus Hörer, Uwe Michaelis, Richard B.S. Roden, Lutz Gissmann, Jürgen A. Kleinschmidt.

Effective treatment of pancreatic tumors with two multimutated ...

typeset.io

Sunil K. Geevarghese 1, David A. Geller, Hans A. de Haan, Markus Hörer, Anette Knoll, Axel Mescheder, John Nemunaitis, Tony R. Reid, Daniel Y. Sze, ... › papers

Meet the teamAscend Gene & Cell Therapies

www.ascend-gctx.com

Mike Stella, CEO · Tim Funnell, Founder & Executive Director · Arjan Roozen, Chief Operating Officer · Markus Hörer, Chief Scientific Officer · Wes McConnell, Chief ...

Microbiology | PLOS ONE

journals.plos.org

... Hanna Seitz, Martin Müller, Markus Kellner, Markus Hörer, Uwe Michaelis, Richard B. S. Roden, Lutz Gissmann, Jürgen A. Kleinschmidt. › browse

Search Results - Manzano-Szalai, Krisztinautb.cz

vufind-test.katalog.k.utb.cz

... Judit Fazekas, Uwe Michaelis, Markus Hörer, Franziska Roth-Walter, Margit Weghofer, Mirko Ritter, Kerstin Pino Tossi, Krisztina Manzano-Szalai.

Recombinant Adeno-Associated Virus for the Generation of ...

www.liebertpub.com

von G Maass · · Zitiert von: 45 — Gerhard Maass · Christoph Bogedain · Ursula Scheer · Doris Michl · Markus Hörer · Markus Braun-Falco · Matthias Volkenandt · Dirk Schadendorf ... › abs

Temp - Team - 2A Pharma

2apharma.com

2A Pharma's history starts in when John Nieland, then Head of Immunology at Medigene AG together with colleagues Markus Hörer and Hildegard Büning, ... › temp-team › temp-tl

Viral vector bioprocessing & analytics: tools and innovations to ...

insights.bio

What is 'quality' in viral vector manufacture? Strengths and limitations of current analytical tools. Markus Hörer. 5 May › spotlights › Vi...

Washington, DC SEC.gov

www.sec.gov

Our co-founder and Chief Technology Officer, Markus Hörer, is an AAV expert and leads our AAV platform development, including manufacturing and analytics ... › Archives › edgar › data

ZUKUNFT DENKEN, STÄRKEN NUTZEN - PDF Free Download

docplayer.org

MARKUS HÖRER MODELL KNOW-HOW Leidenschaft MediGene AG ERSTKLASSIGE MITARBEITER Arbeit in einer Zukunfts branche setzt Neugier und Initiative, ... › Zukunft-denken-sta...

Gene & cell therapy manufacturer Ascend launches with more ...biotech-now.co.uk

www.biotech-now.co.uk

— ... also includes chief financial officer Wes McConnell, chief scientific officer Markus Hörer, and chief operating officer Arjan Roozen.

Development of AAVLP(HPV16/31L2) Particles as Minerva

minerva.unimi.it

... Sebastian ; Karanam, Balasubramanyam ; Seitz, Hanna ; Müller, Martin ; Kellner, Markus ; Hörer, Markus ; Michaelis, Uwe ; Roden, Richard B S ; Gissmann, ... › fulldisplay